T

Trellis Bioscience

17 employees

Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.

Investor insights

Funding rounds participated in

$14M sweet spot round size

Most of their 1 investments are in rounds between $14M and $14M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

1998

Investments made

U

Undisclosed raised $14M on May 24, 2006

Investors: Morgenthaler, HealthCare Ventures LLC, Easton Capital Investment Group and Trellis Bioscience

Funding rounds raised

Total raised

$10M

from 3 investors over 3 rounds

T

Trellis Bioscience raised $3.2M on October 1, 2019

Investors: CARB-X

T

Trellis Bioscience raised $10M on February 14, 2007

Investors: Morgenthaler and Easton Capital Investment Group

FAQ